IM Cannabis Corp. Appoints New CFO

Ticker: IMCC · Form: 6-K · Filed: Dec 12, 2025 · CIK: 1792030

Im Cannabis CORP. 6-K Filing Summary
FieldDetail
CompanyIm Cannabis CORP. (IMCC)
Form Type6-K
Filed DateDec 12, 2025
Risk Levellow
Pages1
Reading Time2 min
Sentimentneutral

Sentiment: neutral

Topics: executive-appointment, cfo-change

Related Tickers: WW

TL;DR

IM Cannabis Corp. has a new CFO, Asi Levi, effective Dec 11, 2025.

AI Summary

On December 11, 2025, IM Cannabis Corp. appointed Asi Levi as its new Chief Financial Officer, replacing Uri Birenberg who resigned for personal reasons. Mr. Levi brings over 15 years of financial experience, including a previous CFO role at Water Ways Technologies Inc.

Why It Matters

A change in CFO can signal shifts in financial strategy or stability for the company.

Risk Assessment

Risk Level: low — This filing is a routine executive appointment announcement.

Key Players & Entities

FAQ

When was Asi Levi appointed as CFO?

Asi Levi was appointed as CFO on December 11, 2025.

Who did Asi Levi replace as CFO?

Asi Levi replaced Uri Birenberg as CFO.

Why did Uri Birenberg resign?

Uri Birenberg resigned for personal reasons.

What is Asi Levi's prior relevant experience?

Asi Levi has over 15 years of experience in finance and controlling roles, including serving as CFO of Water Ways Technologies Inc.

What is the filing form type?

The filing form type is a 6-K.

Filing Stats: 438 words · 2 min read · ~1 pages · Grade level 10.3 · Accepted 2025-12-12 16:05:02

Filing Documents

From the Filing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2025 Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F Form 40-F CONTENTS On December 11, 2025, the board of directors of IM Cannabis Corp. (the "Company") appointed Mr. Asi Levi as the Company's Chief Financial Officer, effective immediately. Mr. Levi will replace Mr. Uri Birenberg, who resigned from his position as the Company's Chief Financial Officer for personal reasons. Mr. Levi has over 15 years of experience in finance and controlling roles, including serving as chief financial officer of Water Ways Technologies Inc. (TSXV: WWT) and DekelOil CI (part of Dekel Agri-Vision Plc (AIM: DKL)), and as controller of SciSparc Ltd. (Nasdaq: SPRC) and A2Z Cust2Mate Solutions Corp. (Nasdaq: AZ). He has overseen fundraising efforts and handled financial planning, budgeting, and cash flow management in compliance with international financial reporting standards (IFRS) and other standards. In connection with this appointment, the Company expects to enter into its standard form of indemnification agreement with Mr. Levi on the same terms as the indemnification agreements previously entered into between the Company and each of its directors and executive officers. There are no related party transactions involving Mr. Levi required to be disclosed under Item 7.B of Form 20-F. On December 12, 2025, the Company issued a press release titled "IM Cannabis Appoints Asi Levi as Chief Financial Officer," a copy of which is furnished as Exhibit 99.1 with this Report of Foreign Private Issuer on Form 6-K (this "Report"). This Report is incorporated by reference into the Company's Registration Statements on Form F-3 (File No. 333-289571 and 333-288346 ) filed with the Securities and Exchange Commission to be a part thereof from the date on which this Report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished. EXHIBIT INDEX Exhibit No. 99.1 Press Release dated December 12, 2025 titled "IM Cannabis Appoints Asi Levi as Chief Financial Officer". SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. IM CANNABIS CORP. Date: December 12, 2025 By: /s/ Oren Shuster Name: Oren Shuster Title: Chief Executive Officer and Director

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing